105 related articles for article (PubMed ID: 19461400)
1. Alternative splicing in lung cancer.
Pio R; Montuenga LM
J Thorac Oncol; 2009 Jun; 4(6):674-8. PubMed ID: 19461400
[TBL] [Abstract][Full Text] [Related]
2. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
Dauksaite V; Akusjärvi G
Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel cis-element that regulates alternative splicing of Bcl-x pre-mRNA.
Lee J; Zhou J; Zheng X; Cho S; Moon H; Loh TJ; Jo K; Shen H
Biochem Biophys Res Commun; 2012 Apr; 420(2):467-72. PubMed ID: 22440396
[TBL] [Abstract][Full Text] [Related]
4. Emetine regulates the alternative splicing of Bcl-x through a protein phosphatase 1-dependent mechanism.
Boon-Unge K; Yu Q; Zou T; Zhou A; Govitrapong P; Zhou J
Chem Biol; 2007 Dec; 14(12):1386-92. PubMed ID: 18096507
[TBL] [Abstract][Full Text] [Related]
5. Spatio-temporal expression of the trans-acting splicing factors SF2/ASF and heterogeneous ribonuclear proteins A1/A1B in the myometrium of the pregnant human uterus: a molecular mechanism for regulating regional protein isoform expression in vivo.
Pollard AJ; Sparey C; Robson SC; Krainer AR; Europe-Finner GN
J Clin Endocrinol Metab; 2000 May; 85(5):1928-36. PubMed ID: 10843177
[TBL] [Abstract][Full Text] [Related]
6. ASF/SF2-like maize pre-mRNA splicing factors affect splice site utilization and their transcripts are alternatively spliced.
Gao H; Gordon-Kamm WJ; Lyznik LA
Gene; 2004 Sep; 339():25-37. PubMed ID: 15363843
[TBL] [Abstract][Full Text] [Related]
7. SF2/ASF regulates proteomic diversity by affecting the balance between translation initiation mechanisms.
Blaustein M; Quadrana L; Risso G; Mata Mde L; Pelisch F; Srebrow A
J Cell Biochem; 2009 Jul; 107(4):826-33. PubMed ID: 19441081
[TBL] [Abstract][Full Text] [Related]
8. Disturbed expression of type 1 iodothyronine deiodinase splice variants in human renal cancer.
Piekielko-Witkowska A; Master A; Wojcicka A; Boguslawska J; Brozda I; Tanski Z; Nauman A
Thyroid; 2009 Oct; 19(10):1105-13. PubMed ID: 19534619
[TBL] [Abstract][Full Text] [Related]
9. The connection between splicing and cancer.
Srebrow A; Kornblihtt AR
J Cell Sci; 2006 Jul; 119(Pt 13):2635-41. PubMed ID: 16787944
[TBL] [Abstract][Full Text] [Related]
10. Alternative splicing of BCL-x is controlled by RBM25 binding to a G-quadruplex in BCL-x pre-mRNA.
Le Sénéchal R; Keruzoré M; Quillévéré A; Loaëc N; Dinh VT; Reznichenko O; Guixens-Gallardo P; Corcos L; Teulade-Fichou MP; Granzhan A; Blondel M
Nucleic Acids Res; 2023 Nov; 51(20):11239-11257. PubMed ID: 37811881
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation.
Dou Z; Zhao D; Chen X; Xu C; Jin X; Zhang X; Wang Y; Xie X; Li Q; Di C; Zhang H
J Exp Clin Cancer Res; 2021 Jun; 40(1):194. PubMed ID: 34118966
[TBL] [Abstract][Full Text] [Related]
12. PLP1 alternative splicing in differentiating oligodendrocytes: characterization of an exonic splicing enhancer.
Wang E; Huang Z; Hobson GM; Dimova N; Sperle K; McCullough A; Cambi F
J Cell Biochem; 2006 Apr; 97(5):999-1016. PubMed ID: 16288477
[TBL] [Abstract][Full Text] [Related]
13. cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing.
Liao HJ; Baker CC; Princler GL; Derse D
Virology; 2004 May; 323(1):131-40. PubMed ID: 15165825
[TBL] [Abstract][Full Text] [Related]
14. [Disturbances of alternative splicing in cancer].
Wiszomirska H; Piekiełko-Witkowska A; Nauman A
Postepy Biochem; 2011; 57(3):257-65. PubMed ID: 22235651
[TBL] [Abstract][Full Text] [Related]
15. Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways.
Gonçalves V; Matos P; Jordan P
Hum Mol Genet; 2009 Oct; 18(19):3696-707. PubMed ID: 19602482
[TBL] [Abstract][Full Text] [Related]
16. Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides.
Taylor JK; Zhang QQ; Wyatt JR; Dean NM
Nat Biotechnol; 1999 Nov; 17(11):1097-100. PubMed ID: 10545916
[TBL] [Abstract][Full Text] [Related]
17. Cis-acting intronic elements that regulate cartilage-specific alternative splicing of the type II collagen (Col2) pre-mRNA lie at or near splice site junction sequences flanking exon 2 of the gene.
Nishiyama T; Hatano H; Kurosaka M; Bolander ME; Sarkar G
J Bone Miner Res; 2003 Sep; 18(9):1716-22. PubMed ID: 12968682
[TBL] [Abstract][Full Text] [Related]
18. Amiloride modulates alternative splicing in leukemic cells and resensitizes Bcr-AblT315I mutant cells to imatinib.
Chang WH; Liu TC; Yang WK; Lee CC; Lin YH; Chen TY; Chang JG
Cancer Res; 2011 Jan; 71(2):383-92. PubMed ID: 21224352
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing in lung cancer.
Coomer AO; Black F; Greystoke A; Munkley J; Elliott DJ
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194388. PubMed ID: 31152916
[TBL] [Abstract][Full Text] [Related]
20. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
